Dose Response Trial of Pergolide for Cocaine Dependence - 1
Primary Purpose
Cocaine-Related Disorders
Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Pergolide
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Medical University of South Carolina
Outcomes
Primary Outcome Measures
Side effects
Drug use
Retention
Cocaine withdrawal
Compliance
Effectiveness of medication for global improvements
Secondary Outcome Measures
Full Information
NCT ID
NCT00000248
First Posted
September 20, 1999
Last Updated
May 15, 2018
Sponsor
Medical University of South Carolina
Collaborators
National Institute on Drug Abuse (NIDA)
1. Study Identification
Unique Protocol Identification Number
NCT00000248
Brief Title
Dose Response Trial of Pergolide for Cocaine Dependence - 1
Official Title
Dose Response Trial of Pergolide for Cocaine Dependence
Study Type
Interventional
2. Study Status
Record Verification Date
May 1997
Overall Recruitment Status
Completed
Study Start Date
February 1996 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Medical University of South Carolina
Collaborators
National Institute on Drug Abuse (NIDA)
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Pergolide
Primary Outcome Measure Information:
Title
Side effects
Title
Drug use
Title
Retention
Title
Cocaine withdrawal
Title
Compliance
Title
Effectiveness of medication for global improvements
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert Malcolm, M.D.
Organizational Affiliation
Medical University of South Carolina
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425 742
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
9134073
Citation
Malcolm R, Moore JW, Kajdasz DK, Cochrane CE. Pergolide mesylate. Adverse events occurring in the treatment of cocaine dependence. Am J Addict. 1997 Spring;6(2):117-23. doi: 10.3109/10550499709137022.
Results Reference
background
Learn more about this trial
Dose Response Trial of Pergolide for Cocaine Dependence - 1
We'll reach out to this number within 24 hrs